Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY22.90 CNY
Change Today -0.88 / -3.70%
Volume 6.8M
002412 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

hunan hansen pharmaceutica-a (002412) Snapshot

Open
CNY23.84
Previous Close
CNY23.78
Day High
CNY24.10
Day Low
CNY22.81
52 Week High
04/17/15 - CNY26.42
52 Week Low
04/29/14 - CNY14.00
Market Cap
6.8B
Average Volume 10 Days
9.0M
EPS TTM
CNY0.41
Shares Outstanding
296.0M
EX-Date
05/23/14
P/E TM
55.7x
Dividend
CNY0.25
Dividend Yield
1.09%
Current Stock Chart for HUNAN HANSEN PHARMACEUTICA-A (002412)

Related News

No related news articles were found.

hunan hansen pharmaceutica-a (002412) Related Businessweek News

No Related Businessweek News Found

hunan hansen pharmaceutica-a (002412) Details

Hunan Hansen Pharmaceutical Co., Ltd. is engaged in the research, development, production, and distribution of Chinese traditional medicines for the treatment of gastrointestinal, orthopedic traumatism, cardiovascular, cerebrovascular, and other diseases. It produces various forms of medicine, including tablets, capsules, granules, pills, soft extracts, syrups, oral liquids, tinctures, large-volume and small-volume injections, psychotropic substances, and bulk drugs, as well as others. The company’s principal products include Simotang oral liquid used to treat abdominal distention and phlegmatic abdominalgia; Yushangling capsules used for injuries from falls; Yinxingye capsules for stroke and chest distress; Suoquan capsules used for kidney deficiency; respiratory system drugs; traumatology medication products; and diagnostic agents. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China.

hunan hansen pharmaceutica-a (002412) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hunan hansen pharmaceutica-a (002412) Key Developments

Hunan Hansen Pharmaceutical Co., Ltd. to Report Q1, 2015 Results on Apr 25, 2015

Hunan Hansen Pharmaceutical Co., Ltd. announced that they will report Q1, 2015 results on Apr 25, 2015

Hunan Hansen Pharmaceutical Co., Ltd., 2014 Earnings Call, Apr 27, 2015

Hunan Hansen Pharmaceutical Co., Ltd., 2014 Earnings Call, Apr 27, 2015

Hunan Hansen Pharmaceutical Co., Ltd. to Report Fiscal Year 2014 Results on Apr 17, 2015

Hunan Hansen Pharmaceutical Co., Ltd. announced that they will report fiscal year 2014 results on Apr 17, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002412:CH CNY22.90 CNY -0.88

002412 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002412.
View Industry Companies
 

Industry Analysis

002412

Industry Average

Valuation 002412 Industry Range
Price/Earnings 60.0x
Price/Sales 9.5x
Price/Book 6.3x
Price/Cash Flow 60.0x
TEV/Sales 9.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HUNAN HANSEN PHARMACEUTICA-A, please visit www.hansenzy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.